Eva Germovsek

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

A Time-to-Event Model Relating Integrated Craving to Risk of Smoking Relapse Across Different Nicotine Replacement Therapy Formulations.

A Time-to-Event Model Relating Integrated Craving to Risk of Smoking Relapse Across Different Nicotine Replacement Therapy Formulations.

Journal: Clinical pharmacology and therapeutics

Published: March 16, 2020

Relating Nicotine Plasma Concentration to Momentary Craving Across Four Nicotine Replacement Therapy Formulations.

Relating Nicotine Plasma Concentration to Momentary Craving Across Four Nicotine Replacement Therapy Formulations.

Journal: Clinical pharmacology and therapeutics

Published: May 29, 2019

Correction to: Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance.

Correction to: Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance.

Journal: Clinical pharmacokinetics

Published: December 19, 2018

A Novel Method for Analysing Frequent Observations from Questionnaires in Order to Model Patient-Reported Outcomes: Application to EXACT® Daily Diary Data from COPD Patients.

A Novel Method for Analysing Frequent Observations from Questionnaires in Order to Model Patient-Reported Outcomes: Application to EXACT® Daily Diary Data from COPD Patients.

Journal: The AAPS journal

Published: November 20, 2018

Development and external evaluation of a population pharmacokinetic model for continuous and intermittent administration of vancomycin in neonates and infants using prospectively collected data.

Development and external evaluation of a population pharmacokinetic model for continuous and intermittent administration of vancomycin in neonates and infants using prospectively collected data.

Journal: The Journal of antimicrobial chemotherapy

Published: September 05, 2018

Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance.

Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance.

Journal: Clinical pharmacokinetics

Published: April 21, 2018

Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies.

Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies.

Journal: The Journal of antimicrobial chemotherapy

Published: December 15, 2017

Pharmacokinetics of Penicillin G in Preterm and Term Neonates.

Pharmacokinetics of Penicillin G in Preterm and Term Neonates.

Journal: Antimicrobial agents and chemotherapy

Published: November 06, 2017

Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?

Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?

Journal: British journal of clinical pharmacology

Published: May 20, 2016

Development and Evaluation of a Gentamicin Pharmacokinetic Model That Facilitates Opportunistic Gentamicin Therapeutic Drug Monitoring in Neonates and Infants.

Development and Evaluation of a Gentamicin Pharmacokinetic Model That Facilitates Opportunistic Gentamicin Therapeutic Drug Monitoring in Neonates and Infants.

Journal: Antimicrobial agents and chemotherapy

Published: March 14, 2016

What do I need to know about penicillin antibiotics?

What do I need to know about penicillin antibiotics?

Journal: Archives of disease in childhood. Education and practice edition

Published: January 07, 2016

What do I need to know about aminoglycoside antibiotics?

What do I need to know about aminoglycoside antibiotics?

Journal: Archives of disease in childhood. Education and practice edition

Published: December 07, 2015

Showing 1-12 of 14

Last Updated: 09/26/2026